ASCO 2018: Immunotherapy-Based Approaches for Advanced Urothelial Cancer – UroToday
|
ASCO 2018: Immunotherapy-Based Approaches for Advanced Urothelial Cancer
UroToday There are no reliable, predictive biomarkers; There is a relatively low number of responders and we are unclear as to the duration of therapy for those that do respond; We are still unsure what the best setting to use immunotherapy is; Will sequence … |
